TNFRSF1B Signaling Blockade Protects Airway Epithelial Cells from Oxidative Stress

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Immunology

Background:

• Cystic Fibrosis (CF) lung pathology involves progressive airway destruction from unresolved inflammation and oxidative stress.
• Neutrophils in CF release reactive oxygen species (ROS), damaging epithelial cells and exacerbating oxidative stress.
• Previous screening identified Tumor Necrosis Factor Receptor Superfamily Member 1B (TNFRSF1B; TNFR2) as potentially involved in oxidative stress susceptibility in CF cells.

Purpose of the Study:

• To investigate the role of TNFRSF1B in epithelial cell protection against oxidative stress.
• To evaluate the therapeutic potential of blocking the lymphotoxin-alpha (LTA)-TNFR2 signaling axis in CF airway epithelial cells.

Main Methods:

• Demonstrated the protective effect of TNFRSF1B transcript knockdown on epithelial cells under oxidative stress.
• Utilized etanercept, an anti-tumor necrosis factor (TNF) biologic, to block TNFR signaling.
• Performed bioinformatic analyses integrating previous RNA interference (RNAi) screening data.

Main Results:

• Knockdown of TNFRSF1B enhanced epithelial cell protection against oxidative stress.
• Blocking TNFR signaling with etanercept significantly increased the viability of airway epithelial cells exposed to an oxidizing agent.
• Bioinformatic analysis confirmed the involvement of TNFRSF1B and other TNF pathway genes in oxidative stress-induced epithelial cell death.

Conclusions:

• The LTα3-TNFR2 axis is implicated in oxidative stress-induced epithelial cell death in CF.
• Inhibition of the LTα3-TNFR2 pathway represents a promising therapeutic strategy to protect the respiratory airway epithelium in CF patients.
• Targeting this axis could mitigate oxidative damage resulting from recurrent infection and inflammation cycles in CF.